VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2020 | BLC2001: Erdafitinib for mUC

Scott Tagawa, MD, MS, FACP, Weill Cornell Medicine, New York, NY, USA, outlines the BLC2001 trial (NCT02365597), which investigated the use of erdafitinib in locally advanced or metastatic urothelial carcinoma (mUC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter